Peptide record

TPDB05875

DA Antibacterial Anticancer Antifungal Antiparasitic Toxicity Tumor-homing Peptides modified_plain modified
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB05875
DA
Antibacterial Anticancer Antifungal Antiparasitic Toxicity Tumor-homing Peptides
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia CAFPdb dbAMP dbAMP 3.0 i2APP TumorHoPe2.0
modified_plain
Yes
A 9-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, Peptipedia, CAFPdb, and other sources, with an available 3D structural model.
C-terminal: amide group (-NH2)
Sequence
RLYLRIGRR
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
9 reviewed residue count
amide group (-NH2) Activity
RGD Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

endothelial cell
Targeting
integrin αVβ3

Source & Reference

TumorHoPe2.0
TumorHoPe2
Anti-angiogenesis activities of novel peptide complexes: mitochondria-disruptive 9mer peptides conjugated with the integrin alpha V beta 3-homing cyclic RGD motif
2012
Takashi Iwasaki et al. Biosci Biotechnol Biochem. 2012 76(11):2044-8.

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
Cos-1 African green monkey kidney cancer (Riken Cell Bank, RCB0143), HepG2 human liver cancer (RCB1886), NIH-3T3 mouse fibroblastic (RCB2767) cell line,RERF-LC-AI human carcinoma (RCB0444) cell line, Human umbilical vein endothelial cells (HUVECs)
Synthetic
cyclic RGD peptide
Additional Detail Fields 2 fields
cyclic RGD peptide
Cos-1 African green monkey kidney cancer (Riken Cell Bank, RCB0143), HepG2 human liver cancer (RCB1886), NIH-3T3 mouse fibroblastic (RCB2767) cell line,RERF-LC-AI human carcinoma (RCB0444) cell line, Human umbilical vein endothelial cells (HUVECs)